Buserelin versus danazol in the treatment of endometriosis-associated infertility
- 1 October 1989
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 161 (4), 871-876
- https://doi.org/10.1016/0002-9378(89)90739-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.BMJ, 1987
- The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppressionFertility and Sterility, 1987
- Endometriosis—Associated InfertilityObstetrical & Gynecological Survey, 1986
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- Early conception in patients with untreated mild endometriosisFertility and Sterility, 1983
- The effectiveness of danazol on subsequent fertility in minimal endometriosisFertility and Sterility, 1982
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonistFertility and Sterility, 1982